Cargando…
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Regulatory T cells (T(regs)) have been proposed to dampen functions of anti-neoplastic immune cells and thus promote cancer progression. In a phase IV trial (Re:Mission Trial, NCT01347996, http://www.clinicaltrials.gov) 84 patients (age 18–79) with acute myeloid leukemia (AML) in first complete remi...
Autores principales: | Sander, Frida Ewald, Nilsson, Malin, Rydström, Anna, Aurelius, Johan, Riise, Rebecca E., Movitz, Charlotta, Bernson, Elin, Kiffin, Roberta, Ståhlberg, Anders, Brune, Mats, Foà, Robin, Hellstrand, Kristoffer, Thorén, Fredrik B., Martner, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645432/ https://www.ncbi.nlm.nih.gov/pubmed/28721449 http://dx.doi.org/10.1007/s00262-017-2040-9 |
Ejemplares similares
-
Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia
por: Sander, Frida Ewald, et al.
Publicado: (2016) -
NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
por: Martner, Anna, et al.
Publicado: (2015) -
Role of natural killer cell subsets and natural cytotoxicity receptors for
the outcome of immunotherapy in acute myeloid leukemia
por: Martner, Anna, et al.
Publicado: (2015) -
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2018) -
Role of the ERK Pathway for Oxidant-Induced Parthanatos in Human Lymphocytes
por: Akhiani, Ali A., et al.
Publicado: (2014)